Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Health dept data shows 1.93m reported cases of respiratory disease in 30 days; complaints of asthma, conjunctivitis, heart ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

The researchers ... Burning Incense Can Pose Health Risks for Those With Allergies and Asthma Oct. 24, 2024 — A new medically challenging case warns that, for those with allergies and asthma ...

Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP –– Commenced startup for a Phase 2 clinical trial in ...

Jay'd Cridele has had severe asthma all her life. For 14 years, simple activities, like playing with her siblings, were ...

Chronic spontaneous urticaria is an inflammatory skin disease that causes hives that last for at least six weeks. Derms ...

There’s currently no cure for asthma, but treatment and lifestyle measures can help manage your symptoms. One way is to reduce your exposure to allergens in the environment that can trigger your ...

A disqualifying disposition essentially turns your incentive stock option into an NSO, disqualifying them from favorable tax treatment. There is no tax liability when you exercise the options and ...

The drug, Orlynvah, has been approved to treat uncomplicated UTIs in women who have limited oral antibacterial treatment options or none at all. UTI is a common bacterial infection of the bladder ...